Concepedia

Matthew D. Smith

MD

Statistics

Publications

21

Citations

1.3K

H-Index

19

Active since

2002

Affiliations

University of North Carolina at Chapel Hill(Current)

University of California, Los Angeles

Shanghai Medical College of Fudan University

Molecular Oncology (United States)

University of California San Diego

Matthew D. Smith is an author at University of North Carolina at Chapel Hill specializing in medicine, cell biology, and developmental biology.

ORCID

Top concepts

Publications per year

2002–2023

21

Publications

21

Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy

Yanping Xu, Lei Lv, Ying Liu et al. · Journal of Clinical Investigation · 2019 · 223 citations · Full text

, , +16

Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses

Leilei Chen, Carmen Morcelle, Zhou‐Li Cheng et al. · Nature Cell Biology · 2022 · 186 citations · Full text

, , +5

CDK Inhibitor p18INK4c Is a Downstream Target of GATA3 and Restrains Mammary Luminal Progenitor Cell Proliferation and Tumorigenesis

Xin‐Hai Pei, Feng Bai, Matthew D. Smith et al. · Cancer Cell · 2009 · 112 citations · Full text

, , +9

<i>BRCA1</i> Suppresses Epithelial-to-Mesenchymal Transition and Stem Cell Dedifferentiation during Mammary and Tumor Development

Feng Bai, Ho Lam Chan, Alexandria Scott et al. · Cancer Research · 2014 · 88 citations

, , +17

p18 <sup> <i>Ink4c</i> </sup> , but Not p27 <sup> <i>Kip1</i> </sup> , Collaborates with <i>Men1</i> To Suppress Neuroendocrine Organ Tumors

Feng Bai, Xin‐Hai Pei, Toru Nishikawa et al. · Molecular and Cellular Biology · 2006 · 69 citations · Full text

1–5 of 21